Video

Most Common Myth About Clinical Trials

Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, addresses a common myth about clinical trials.

Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, addresses a common myth about clinical trials.

People often think clinical trials benefit doctors and science more than they help the people who participate in them. Clinical trials are actually better, more advanced care.

To be able to get through the Food and Drug Administration's regulations today, the burden of proof to be able to do a clinical trial is much higher than in the past. The likelihood of responding well in a safety, tolerability and proof-of-concept study is much better, as well as trial studies in later phases.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Photo of Dr. Rosario Ligresti
Image of women with text.
CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.